Fulminant hepatic failure. Unusual cardiac failure presentation.

被引:0
|
作者
Ridruejo, E
Laurini, J
Cingolani, O
机构
[1] CEMIC, Dept Med Interna, Secc Clin Med, Buenos Aires, DF, Argentina
[2] CEMIC, Serv Patol, Buenos Aires, DF, Argentina
关键词
heart failure; fulminant liver failure; ischemic liver disease; cardiogenic shock;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive liver disease can be one of the clinical aspects of chronic heart failure. Fulminant hepatic failure can be a consequence of ischemic liver disease secondary to cardiogenic shock. We report a patient with chronic heart failure who was admitted to our hospital presenting general malaise with abnormal liver function tests, prothrombin time and renal failure. The study of viral and autoimmune liver diseases were negative. She did not consume hepatotoxic drugs. She presented encephalopathy without initial evidence of shock. On the fourth day, she presented clinical deterioration compatible with cardiogenic shock. Laboratory abnormalities were similar to those seen in congestive and ischemic liver disease. The patient died 24 hours later. The histology showed congestive and ischemic liver disease. There are several reports of chronic liver diseases without a clear etiology, caused by constrictive pericarditis or restrictive myocardiopathy. In this case, the patient presented fulminant hepatic failure without clear evidence of progressive heart failure. We emphasize the importance of cardiac diseases as possible causes of liver diseases without another clear explanation.
引用
收藏
页码:491 / 494
页数:4
相关论文
共 50 条
  • [21] Prognostic Value of MELD Score in Patients with Fulminant Hepatic Failure.
    Lee, Hyung Soon
    Choi, Gi Hong
    Joo, Dong Jin
    Kim, Myoung Soo
    Kim, Soon Il
    Choi, Jin Sub
    LIVER TRANSPLANTATION, 2012, 18 : S197 - S197
  • [22] Cerebral microdialysis of glutamate and lactate in patients with fulminant hepatic failure.
    Tofteng, F
    Jorgensen, L
    Hansen, BA
    Ott, P
    Kondrup, J
    Larsen, FS
    HEPATOLOGY, 2001, 34 (04) : 658A - 658A
  • [23] Pediatric living related liver transplantation for fulminant hepatic failure.
    Shapiro, R
    Mor, E
    Bar-Nathan, N
    Shaharabani, E
    Dinari, G
    Ben Ari, Z
    LIVER TRANSPLANTATION, 2004, 10 (06) : C60 - C60
  • [24] IL-18 production in patients with fulminant hepatic failure.
    Shinoda, M
    Wakabayashi, G
    Shimazu, M
    Hoshino, K
    Tanabe, M
    Morikawa, Y
    Kitajima, M
    HEPATOLOGY, 2001, 34 (04) : 283A - 283A
  • [25] The role of GBV-C/HGV in fulminant hepatic failure.
    Takikawa, Y
    Suzuki, K
    Endo, R
    Iwai, M
    Abe, K
    Ishikawa, K
    Sato, S
    GASTROENTEROLOGY, 1998, 114 (04) : A1352 - A1352
  • [26] Utility of intracranial pressure monitoring in patients with fulminant hepatic failure.
    Schwarz, A
    Rajvanshi, PR
    Larson, AM
    Kowdley, KV
    HEPATOLOGY, 2000, 32 (04) : 339A - 339A
  • [27] Prevalence of TT virus in Japanese patients with fulminant hepatic failure.
    Tanaka, M
    Nishiguchi, S
    Enomoto, M
    Tanaka, T
    Minamitani, S
    Fukuda, K
    Habu, D
    Takeda, T
    Shiomi, S
    Seki, S
    Kuroki, T
    Yano, Y
    Otani, S
    HEPATOLOGY, 1998, 28 (04) : 291A - 291A
  • [28] Emergency living donor liver transplantation for fulminant hepatic failure.
    Kakodkar, R.
    Soin, A. S.
    Saigal, S.
    Nundy, S.
    LIVER TRANSPLANTATION, 2007, 13 (06) : S100 - S100
  • [29] Characterization of hepatic microcirculatory changes in azoxymethane-induced fulminant hepatic failure.
    Wawrzyniak, AJ
    Schrum, LW
    Bost, KL
    Clemens, MG
    Zhang, JX
    HEPATOLOGY, 2001, 34 (04) : 200A - 200A
  • [30] The hepaxoprotective effect of difluorometrylornithine: Studies in rat models of fulminant hepatic failure.
    Cinar, K
    Celik, T
    Bozkaya, H
    Karaaslan, H
    Uzunalimoglu, O
    Uzbay, T
    Jones, AE
    Yurdaydin, C
    HEPATOLOGY, 2002, 36 (04) : 168A - 168A